PepGen Inc.
Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.
PEPG | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7133171055
- LEI:
- Country:
- United States of America
- Address:
- 1 MARINA PARK DRIVE, SUITE 900, 2210 BOSTON
- Website:
- https://pepgen.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
PepGen Inc. is a clinical-stage biotechnology company focused on developing a new generation of disease-modifying therapies. The company is creating a pipeline of therapeutics aimed at treating severe, genetic neuromuscular and neurological diseases by targeting their root cause. PepGen utilizes its proprietary Enhanced Delivery Oligonucleotide (EDO) platform to optimize the delivery of therapeutic oligonucleotides, with the goal of advancing transformative treatments for patients with devastating conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PepGen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PepGen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PepGen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
